LRRK2 and Parkinson disease: By comparing individuals with idiopathic PD, LRRK2 PD, asymptomatic LRRK2 carriers, and non-carrier controls, we sought to identify potential immune-related markers in serum and CSF associated with PD and LRRK2 mutation status.